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A B S T R A C T    
	  
The  syntheses of three novel chiral 4,40 BOX ligands are  described. The  three ligands each have a chiral 
backbone and chiral sidearms, two of  which are  diastereomeric. These new ligands have been applied as 
copper complexes to asymmetric cyclopropanation reaction of styrene with ethyldiazoacetate. Enanti- 
oselectivities of up to 70% were obtained, which is the highest ee reported from the use of this ligand class in  
this reaction to date. The  multiple stereogenic centres in  the ligand resulted in  a substantial additive effect 
and this is  discussed along with interpretation  of  the results for  previously described 4,40 BOX ligands, 
and a major computational study of the multiple reaction channels involved with ligands of this type. The  
use of complexes of 4,40 BOX ligands, as catalysts, in an  allylic alkylation is also reported for the 
ﬁrst time and ee’s of >70% have been achieved in this reaction. These ligands were also applied to a Diels– 
Alder test reaction and again outperformed previous examples of this ligand type. 
 
	  
	  
	  
	  
	  
	  
	  
1. Introduction 
	  
 
Chiral  2,2’-bis(oxazoline) (BOX)  ligands were  ﬁrst  reported 20 
years ago1,2 and since this time a large number of such ligands have 
been reported on.3  They  have been applied, as  their metal complexes, 
to the asymmetric catalysis of a wide variety of key or- ganic reactions, 
such as cyclopropanations,4,5  Diels  Alder  cycload- ditions,6  ene   
reactions,7  Mukaiyama aldol reactions8   and so  on. The  structure of  
the metal complexes has  also  been widely explored. Despite the success 
of these and other catalysts, there is still  a need to  develop new 
catalysts, which increase the toolbox available to  those interested in 
developing asymmetric syntheses. In general, the BOX ligands reported 
to  date are  predominantly based around the same ligand backbone with 
variation in the pendant groups at the two available positions in the 
oxazoline ring  or on the bridgehead carbon. 
We have recently reported the ﬁrst examples of 4,40 BOX ligands 
(Fig.  1).9–11  In these ligands, the backbone contains stereogenic 
centres and upon complexation with a metal, these chiral centres are  
internal to  the metallocycle. These initial ligands have been used in the 
catalysis of Diels–Alder and cyclopropanation reactions with some 
success. 
 
 
 
 
 
 
Figure 1.  4,4’-BOX ligands previously reported by  this group. 
 
 
The ligands are derived from two different commercially avail- able  
alcohols; arabitol leading to  the AraBOX ligands and xylitol leading to  the 
XyliBOX ligands which are  meso  unless additional chirality is incorporated 
into the pendant groups on  the oxazoline rings (3 vs 4 and 5).
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2. Results and discussion 
	  
We  wanted to  evaluate the inﬂuence of  the chirality in  the 
backbone of the ligand on  the stereoselectivity achieved by the li- 
gand’s copper complexes in  the asymmetric cyclopropanation of 
styrene. Furthermore, we  wanted to see  what inﬂuence chiral pen- 
dant groups would have on  the stereoselectivity. To that end we 
synthesized three novel 4,40 BOX ligands 9–11 (Scheme 1). 
We  have previously reported on  the synthesis of  12  starting 
from D-(+)-arabitol; this was  used as the starting point for the syn- 
thesis of ligand 11.9  The  enantiomeric TBDMS protected bis-ami- 
noalcohol 6  was  prepared from L-(-)-arabitol  and this was  used 
as  the starting point for  the synthesis of ligands 9 and 10.  In  all 
cases, the amines were reacted with chiral acid  chlorides to  form 
amides. The  acid  chlorides were prepared from chiral acids and 
thionyl chloride and were used without puriﬁcation beyond sol- 
vent removal. Amides 8 and 13  were isolated in  good  yield while 
7 was  isolated in modest 35% yield. We  have developed a tandem 
deprotection, activation and ring  closure reaction for the synthesis 
of  our  previous ligands and we  again applied this methodology. 
Tosyl ﬂuoride was  used to deprotect the alcohols and activate them 
as  tosylates, thus facilitating the ring   closure. The  DBU plays a 
catalytic role  in the deprotection reaction but is required in excess 
in  the  cyclization step. This   method  allows the  ligands to   be 
prepared in   excellent  yields (up   to   66%)  considering that  the 
tandem DARC reactions involve 6 separate synthetic steps (three 
on  each side). 
We  now had available to  us  three new 4,40 BOX ligands, and 
eight in total, which we then applied to the asymmetric cycloprop- 
anation reaction of styrene with ethyl diazoacetate (Table  1). We 
were particularly interested in  the two diastereomeric ligands 10 
and 11,  which would give  us  some insight into the relative inﬂu- 
ence of the chirality in  the backbone and in  the pendant groups 
on  the stereochemical outcome of the reaction. 
The  reactions were conducted using 10 mol  %  of the copper(I) 
triﬂate ligand complex relative to  ethyl diazoacetate and a three 
fold  excess of styrene. The  results for ligands 1–5  have previously 
been reported on but are  included here for the sake of comparison 
	  
 
Scheme 1.  Synthetic steps involved in the synthesis of ligands 9–10. 
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Table 1 
Ligand performance in the copper(I) catalysed asymmetric cyclopropanation reaction 
At ﬁrst, we  calculated the structure of the cationic 1–Cu(I)-car- 
bene intermediate, whose optimized geometry was  similar to that 
of  the 1–CuCl2   complex, determined  by  X-ray  diffraction.11Once 
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+ OEt 
N2 
	  
	  
	  
a 
	  
Cu(I)OTf 
ligand, 
CH2Cl2, 
rt. 
	  
	  
a b 
CO2Et 
	  
+ 
	  
CO2Et 
	  
	  
b 
the adequacy of the theoretical level  used to  reproduce molecular 
geometries was  tested, we  started modelling the cyclopropanation 
reaction using ethylene as the alkene. Although the resulting cyclo- 
propane was  not  chiral, the corresponding TS of the approaches of 
ethylene through the Re and Si faces  of the carbene carbon atom of 
the  chiral bisoxazoline–copper complexes were  diastereomeric, 
and hence different in  energy. In  previous studies5,17,18   we  have 
    Ligand Conversion  % trans:cis %ee cis   (major) %ee trans  (major) shown that the main steric interactions responsible for  the enan- 
1 99  60:40  32 (1R,2S) 16 (1R,2R) 
2 99 62:38 14 (1R,2S) 7 (1R,2R) 
3 91 48:52 - - 
4 80 53:47 24 (1S,2R) 24 (1S,2S) 
5 99 59:41 6 (1S,2R) 4 (1S,2S) 
9 63  40:60  70 (1S,2R) 69 (1S,2S) 
10 66 59:41 20 (1R,2S) 8 (1R,2R) 
    11 67 37:63 64 (1S,2R) 61 (1S,2S) 	  
a  The  conversion and trans/cis ratio were determined by  1H NMR. 
b  Determined by  chiral GC (Cyclodex-B 30 m x 0.252 mm x 0.25 lm) 
	  
as they allow us to build a picture of the stereochemical inﬂuence 
of each portion of the ligand. 
In all  cases, the ligands proved to  be  ineffective in  inﬂuencing 
the diastereoselectivity of the reaction to  any  major degree. How- 
ever,  the enantioselectivities were much more encouraging. 
Ligands 1 and 2 both gave  low  enantioselectivities, which indi- 
cated that the chiral backbone did  inﬂuence the enantioselectivity 
of the reaction. Although these two ligands are  derived from the 
opposite enantiomers of arabitol, they favour the same enantiomer 
of the product. This behaviour has  previously been seen in copper 
2,20 bis(oxazoline) catalysis of Diels–Alder and ene  reactions.12–16 
In  these cases the alteration was  attributed to  the change in  co- 
ordination geometry around the metal when the pendant groups 
on the oxazoline rings were altered or when extra coordinating li- 
gands/anions were present in the metal co-ordination sphere. This 
change in  co-ordination geometry is often simpliﬁed as  a switch 
between tetrahedral and square planar geometry around the me- 
tal,  although the reality is thought to  be  someway short of these 
extremes. 
The  reaction was,   as  expected, not   stereoselective with the 
meso XyliBOX ligand 3. When the chiral sidearms were added to 
the same backbone to give ligands 4 and 5, then modest enantiose- 
lectivities were obtained. It  was   apparent that  the chirality in 
either the backbone of  the ligand or  in  the sidearms inﬂuenced 
the stereoselectivity of the reaction. Ligands 9–11 were designed 
to  combine both of  these facts.   The  MePrAraBOX  ligand 9  gave 
the  highest enantioselectivities at  rv70%  for   both the  cis-  and 
trans-isomers. The PhPrAraBOX  ligand 10 gave  much lower enanti- 
oselectivity, even though it  had been the more effective sidearm 
with the XyliBOX  backbone. However upon closer examination 
we  realized that the enantiomer of the cyclopropane produced in 
both the cis and trans case  is the opposite of that seen with 9. Given 
that both ligands share a common backbone and the only  differ- 
ence is the chirality and groups on the sidearms, this gave  a strong 
indication that we  were getting a negative effect when the back- 
bone chirality and that  on  the  sidearm were mismatched. The 
PhPrAraBOX   ligand  11,   which is  diastereomeric with  10,   gave 
much better results with enantioselectivities of up  to  64% ee. This 
again gives  very  clear evidence of an  additive effect between the 
stereogenic centres present in ligands 10  and 11. 
In order to gain  some insight on the origin of the enantiodiffer- 
entiation leading to  the enantioselectivities and absolute conﬁgu- 
rations of  the major enantiomers found, we  undertook a 
computational study, based on  the previous successful results ob- 
tained with 2,20 -bisoxazolines.5,17–20 
tioselection are  retained in  this simpliﬁed model, leading to  good 
estimations of the enantioselectivity of real  systems, and,  conse- 
quently, we  adopted the same approach herein. As already men- 
tioned, ethylene can  approach the carbene carbon atom through 
its  Re or  Si faces.   Furthermore, there are   two  conformations  of 
the ester group for each approach. This leads to at least four  possi- 
ble  reaction channels. Whereas the Re TS displays a chelate struc- 
ture almost identical to that of the carbene intermediate, the Si TS 
is  much more deformed, and the six-membered copper chelate 
ring  changes its  conformation from an  initial half-chair to  a boat- 
like  disposition.  Figure 2  highlights these structural  differences 
by superimposing the 1–Cu(I)-carbene intermediate with the min- 
imum energy Re and Si TS, respectively. However, by inspecting the 
relative energies of the four  possible TS, one  realizes that the geo- 
metric deformation observed has  a rather low  energy cost,  since 
three of  the four  TS have almost the same energy. The  modest 
enantioselectivity observed seems to  have its  origin with a slight 
preference of  one  of  the reaction channels over   the other three 
(Fig. 2). The calculated enantioselectivity [39% ee in the (1R)-enan- 
tiomer] is in excellent agreement with the experimental values ob- 
tained (Table  1, ligand 1). 
Next  we  considered the case  of XyliBOX ligands, namely that 
of  MePrXyliBOX   4.  This  situation turned out   to  be  much more 
complex.  First,   due to   the  different absolute conﬁgurations at 
the oxazoline carbon atoms, the ligand is  not   C2-symmetric, so 
the number of  possible alkene approaches to  the corresponding 
carbene intermediate  doubles, since we   must consider the ap- 
proach of  the alkene through the S and R sides, both when the 
ester group is up  and down, which are  now sterically non-equiv- 
alent. Secondly, we  must take into account the possible confor- 
mations not   only   of  the six-membered chelate ring,  but also  of 
the 1-methylpropyl substituent. To  this end,   we  carried out   an 
exploratory  conformational  analysis,  and  we   concluded that, 
with  regard  to   the  methylpropyl substituent,  there  are   three 
main conformational dispositions gathering most of  the confor- 
mational population, as  shown in  Figure 3.  This  means that  if 
we   consider  again  ethylene  as   the  alkene, we   have at  least 
(2 x 2 x 2 x 3  =)  24  possible reaction channels for  the reaction 
(Re/Si  approaches with the ester up/down by  two possible rota- 
mers for  the ester by  three possible conformations for  the meth- 
ylpropyl substituents). 
Table  2 shows the results of the calculated energies. As can  be 
seen, the lowest energy TS corresponds to a Si approach and,  over- 
all,  the (1S)-cyclopropane  product is favoured. Furthermore, only 
the reaction channels through conformation I of the methylpropyl 
substituent contribute signiﬁcantly in determining the enantiose- 
lectivity. Again,  there is  a  reasonably good   agreement between 
the calculated [29% ee in (1S)-cyclopropane] and experimental re- 
sults [24% ee in both  (1S,2R)-cis- and (1S,2S)-trans-cyclopropanes). 
The minimum energy TS, contributing the most to the ﬁnal enanti- 
oselectivity is shown in Figure 4. 
Finally, we  considered the analogous MePrAraBOX  ligand 9. It 
should be  noted that the only  difference with ligand 4 lies  in  the 
absolute conﬁguration of one  of the carbon atoms at C-4, but this 
difference results in  a signiﬁcant asymmetric induction.  Ligand  9 
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Figure 2.  Superimposition of the calculated 1–Cu-carbene geometry (green) with those of the Re (blue) and Si (red) transition structures. Left, zenithal view, right, front view. 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure 3.  Most populated conformations of the methylpropyl substituents in MePrXyliBOX 4. 
	  
	  
Table 2 
Calculated enantioselectivity  in  the reaction of  ethylene with methyl diazoacetate 
catalysed by  the 4–Cu complex 
TS DDG¡,a 
Re/Si  Ester up/down MePr rotam. Ester rotam. 
	  
Re Up  I 1 0.7 
Re Down I 1 0.3 
Re Up  II 1 5.2 
Re Down II 1 3.0 
Re Up  III 1 2.3 
Re Down III 1 5.9 
Re Up  I 2 1.3 
Re Down I 2 1.1 
Re Up  II 2 3.3 
Re Down II 2 4.0 
Re Up  III 2 2.9 
Re Down III 2 5.8 
Si Up  I 1 0.4 
 
	  
Figure 4.  Minimum energy TS for  the Re (left) and Si (right) alkene approaches to 
the 4–Cu-carbene intermediate 
	  
Table 3 
Calculated enantioselectivity  in  the reaction of  ethylene with methyl diazoacetate 
catalysed by  the 9–Cu complex 
Si Down I 1 0.0    
Si Up  II 1 2.6 
SI Down II 1 3.5 
TS DDG¡,a 
	  
Re/Si  MePr rotam. Ester rotam. 
Si Up III 1 2.6    
Si Down III 1 2.8 
Si Up  I 2 1.5 
Si Down I 2 0.3 
Si Up  II 2 2.9 
Si Down II 2 2.9 
Si Up  III 2 3.9 
Si Down III 2 3.8 
Re I 1 1.2 
Re I 2 1.8 
Re II 1 2.3 
Re II 2 4.3 
Re III 1 4.6 
Re III 2 4.0 
Si I 1 0.0 
Si I 2 0.5 
	  
	  
	  
	  
tion channels to  12. 
Table  3 shows the calculated relative energies of the corre- 
sponding TS, while the minimum energy TS contributing the most 
to the ﬁnal enantioselectivity are  shown in Figure 5. As in the case 
of XyliBOX, only  the reaction channels through conformation I of 
the methylpropyl substituent contribute signiﬁcantly to  the reac- 
tion. However, unlike XyliBOX, the AraBOX ligand displays a clear 
preference for the Si reaction channels, leading to a calculated 
enantioselectivity of 75% ee  in  (1S)-cyclopropane,  which is  again 
a   Measured in kcal mol-1. 
	  
	  
in  excellent agreement with the experimental observations [ca. 
70%  ee   in  both   (1S,2R)-cis-  and  (1S,2S)-trans-cyclopropanes].  If 
we compare the minimum energy TS for the Re- and Si-approaches 
(Fig. 5b),  we  can  see  that there are  only  very  minor changes in the 
global geometry of the ligand, associated to the spatial disposition 
of the carbonyl group. These minor changes in the position of one 
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Table 5 
Cu(II)AraBOX complex catalysed Diels–Alder reaction 
	  
	  
Cu(OTf)2 10 mol% 
O ligand 10 mol% O 
N  CH2Cl2, N2, RT  N O 
O  O 
O 
	  
Ligand Conversion (%) endo/exo ee endo 
	  
1 60 70:30 44 (S) 
9 100 82:18 1 (R) 
10 97 70:30 45 (R) 
11 85 64:36 57 (S) 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure 5.  (a)  Minimum energy TS for  the Re (left) and Si (right) alkene approaches 
to the 9-Cu-carbene intermediate. (b)  Superimposition of both TS (red, Re TS, blue, 
Si TS). 
	  
	  
Table 4 
Results of the allylic alkylation reaction using AraBOX  ligands 
moderate  conversion but  showed  diastereoselectivity (de   40% 
endo)   and enantioselectivity (ee  44% in  the endo)   diastereomer. 
The  MePrAraBOX  9  showed good  diastereoselectivity but no 
enantioselectivity. However, the performance of  ligands 10  and 
11  again showed different selectivities. The  complex based on  li- 
gand 10  gave   good   conversion and an  enantioselectivity of  45% 
ee.  The  diastereomeric ligand 11  in the same reaction gave  better 
enantioselectivity (57%).  The  major enantiomer produced by  the 
two diastereomeric ligands is different. This seems to indicate that 
the major control of the enantioselectivity of the reaction comes 
from the chirality in the backbone of the ligand. We  did  see  a co- 
operative effect between the chirality on  the backbone of the li- 
	  
OAc 
	  
Ph Ph 
	  
ligand/Pd2(dba)3 
NaH/DMM 
toluene, 
80oC 
MeO2C 
	  
	  
Ph 
CO2Me 
	  
	  
Ph 
gands and that on the sidearms; the ee of 57% represents the high- 
est  ee we  have recorded in this reaction using the 4,40 BOX ligands. 
We are  currently applying these and related ligands to catalytic 
reactions to  test their reactivity and we  are  also  seeking to  maxi- 
   mize the co-operative effect between various stereogenic centres. 
Ligand     Time (h),  Temperature     Metal salt     Conversion (%)      %ee (R)/(S) 
	  
10 60,  80 Pd2(dba)3 16 6 (R) 
9 60,  80 Pd2(dba)3 99 72 (R) 
11 60,  80 Pd2(dba)3 90 68 (S) 
	  
	  
of the methylpropyl substituents seem to  be  in  the origin of the 
small energy differences leading to  the enantiodiscrimination. 
We also  applied the new ligands 9–11 to the allylic alkylation of 
(±)-(E)-1,3-diphenyl-3-acetoxyprop-1-ene with the anion of di- 
methyl malonate (Table  4). We  hoped that we  would again see  a 
co-operative effect between the chirality on the backbone of the li- 
gands and that on  the sidearms. The  ﬁrst ligand we  tested was  li- 
gand  10,   which  had  performed  well   in   the  cyclopropanation 
reaction. However, the reactivity was  poor as was  the stereoselec- 
tivity. When we  applied ligands 9 and 11 to the reaction however, 
the reactivity was  much higher and the selectivity was  also  im- 
proved. When ligand 9 was  used, the conversion was  99% and the 
product was  produced in  72% ee,  with the (R)-enantiomer  being 
predominant. Ligand  11 also  gave  good  conversion and the product 
in 68% ee, with the (S)-enantiomer being predominant in this case. 
It would seem from the structures of the ligands that the backbone 
chirality has a substantial inﬂuence on the stereochemical outcome 
of the reaction, since the opposite stereochemistry on the backbone 
in 9 and 11 gave  the opposite enantiomer of product diastereomet- 
ric with the same chirality on the sidearms but opposite ligands 10 
and 11  are  chirality in the backbone. The  interaction between the 
chirality in the backbone and that on the sidearms is evident from 
the stereoselectivity achieved with catalysts derived from these 
ligands from 11 leading to 68% ee (S) to 10 giving 6% ee (S). 
We  next applied our  new ligands as their copper(II) complexes 
to the catalysis of Diels–Alder test reactions (Table  5). The phenyl– 
AraBOX ligand 1, which we previously reported gave  the product in 
3. Conclusions 
	  
We  have completed the synthesis of three novel chiral 4,40 BOX 
ligands 9–10. We have applied these ligands to the asymmetric cop- 
per  catalysed cyclopropanation of styrene and achieved enantiose- 
lectivities of up  to 70% ee. We  have conducted a preliminary 
investigation into the factors which affect the enantioselectivity ob- 
tained when using copper complexes of these ligands. The multiple 
stereogenic centres in  the new ligands resulted in  a  substantial 
additive effect. We  are  currently working on  a  computer based 
model in order to fully  explore these effects and assist us in future 
ligand design. An additive effect was  also  observed in the catalysis 
of a Diels–Alder reaction giving the highest ee we have yet recorded 
with 4,40 BOX ligands in this reaction. We have also applied these li- 
gands for the ﬁrst time to the palladium catalysed allylic alkylation 
reaction, achieving ee’s of up to 72%. Our synthetic work in this area 
is currently ongoing particularly in  the application of metal com- 
plexes of these ligands to the catalysis of different reactions. 
	  
4. Experimental 
	  
4.1.  General 
	  
All other chemicals were purchased from Aldrich Chemical 
Company and generally used without further puriﬁcation. Any nec- 
essary reagent puriﬁcation, along with the drying and distillation 
of solvents, was  carried out  according to  literature procedures.21 
Melting points were measured on a Stuart Scientiﬁc SMP3 appara- 
tus.  IR spectra were measured on  a Perkin Elmer Spectrum 1000 
FT-IR, or a Perkin Elmer Spectrum One FT-IR. Optical rotations were 
measured on a Schmidt+Haensch L1000 polarimeter at 589  nm  (Na) 
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in  a 10 cm  cell.  Thin  layer chromatography (TLC) was  carried out 
on precoated silica  gel plates (Merck 60 F254); column chromatog- 
raphy was  conducted using Merck silica  gel 60 or Apollo  Scientiﬁc 
silica  gel 40–63 lm. Elemental analysis was  performed on a Perkin 
Elmer 2400  analyser.  1H NMR  (400 MHz),  13C  NMR  (100 MHz) 
were recorded on  a JEOL ECX-400  NMR spectrometer. All spectra 
were recorded at probe temperatures (rv20 oC) using tetramethyl- 
silane as the internal standard. All chiral liquid–liquid chromatog- 
raphy (HPLC) was  carried out  on a Varian instrument, with an UV/ 
Vis detector at the speciﬁed wavelength, with a Daicel  CHIRALCEL 
OD 0.46  cm x 25 cm  column, using isopropanol/hexane as the sol- 
vent, under conditions described for each experiment. 
	  
4.2.  Preparation of amide 7 
	  
Thionyl chloride (0.27 ml,  3.7 mmol) was  added to  a ﬂask  con- 
taining (S)-(+)-2-methylbutyric acid  (0.27 ml, 2.5 mmol). The solu- 
tion was  heated at reﬂux for  3 h and then concentrated in  vacuo. 
The  residue was  taken up  in  CH2Cl2  and concentrated once more 
to  remove any  remaining thionyl chloride. The  product was  then 
25.9   (6 x CCH3),  18.2   (2 x CCH3),  12.4   (2 x CH3CH2),  -5.6 ppm 
(2 x Si(CH3)2);  IR (neat): m0   = 3314, 2957, 2930, 2857, 1649 cm-1 
(C@O);  HRMS  (ESI):  m/z calcd for  C37H62N2O4Si2-  H+: 653.4170 
[M-H+]; found: 653.4168. Both  1H and 13C NMR showed the pres- 
ence of ethyl acetate which was  extremely difﬁcult to  remove 
completely. 
	  
4.4.  Preparation of amide 13 
	  
Thionyl chloride (0.83 g, 7.0 mmol) was  added to  a  ﬂask  con- 
taining (S)-(+)-2-phenylbutyric acid  (0.77 g, 4.67  mmol). The solu- 
tion was  heated at reﬂux for  3 h and then concentrated in  vacuo. 
The  residue was  taken up  in  CH2Cl2  and concentrated once more 
to  remove any  remaining thionyl chloride. The  product was  then 
dissolved  in   CH2Cl2    and  added  dropwise  to   a  solution  of  12 
(678 mg,  1.87  mmol) and triethylamine  (0.57 ml,  4.11  mmol) at 
0 oC. This  solution was  left  to  stir  for  14 h,  and then warmed to 
room temperature.  The  solution was  then concentrated in  vacuo. 
Puriﬁcation  by   column  chromatography (petrol/ethyl  acetate 
80:20) yielded 13  (910 mg,  74%) as a colourless oil. Rf = 0.60  (pet- 
dissolved in  CH2Cl2  and added dropwise to  a solution of 6 (0.4 g, rol/ethyl acetate 80:20); ½a]20  ¼ þ18:3  (c 0.003, CH CN); 1H NMR 
1.1 mmol) and triethylamine (0.34 ml, 2.5 mmol) at 0 oC. This solu- 
tion was  left  to  stir  for  14 h, then warmed to  room temperature. 
The  solution was  then concentrated in  vacuo. Puriﬁcation by  col- 
umn  chromatography  (petrol/ethyl   acetate   80:20)  yielded  7 
(203 mg,   35%)  as  a  colourless oil.  Rf = 0.3   (petrol/ethyl acetate 
80:20); ½a]20  ¼ -15:2 (c 0.003, CH CN); 1H NMR (400 MHz,  CDCl , 
(400 MHz,  CDCl3,  22 oC, TMS):  d = 7.31–7.21 (m,  10H;  Ar-H),  6.19 
(d,   1J(H,H) = 7.9 Hz,  2H;   2 x NH),  3.74–3.64  (m,   2H;   2 x CHN), 
3.55   (d,  1J(H,H) = 4.6 Hz,  2H;  one   of  CH2OSi),  3.53–3.47 (m,  2H; 
one  of  CH2OSi),  3.26–3.12 (m,  2H;  2 x CHAr), 2.20–2.08 (m,  2H; 
one   of  CH2CH3),   1.83–1.69  (m,   2H;   one   of  CH2CH3),   1.61   (t, 
3J(H,H) = 6.0 Hz,   2H;   CHCH CH),  0.85–0.75  (m,   24H;  2 x t-Bu, D 3 3 2 
22 oC,  TMS):  d = 6.23–6.13 (m,   2H;   2 x NH),  3.89–3.78 (m,   2H; 2 x CH3CH2),    0.08–0.06 ppm   (m,    12H;   Si(CH3)2);    13C    NMR 
2 x CHN),  3.69–3.64  (m,   4H;   2 x CH2OSi),   2.13–2.05  (m,   2H; (100 MHz,    CDCl3, 22 oC,    TMS):    d = 173.6   (2 x C@O),   140.0 
2 x CHCH3),  1.81   (t,  3J(H,H) = 6.4 Hz,  2H;   CHCH2CH),  1.69–1.56 (2 x ArC CH),  128.8  (4 x meta/ortho ArC),  128.1  (4 x meta/ortho 
(m,  2H;  one  of CH2CH3), 1.46–1.35 (m,  2H;  one  of CH2CH3), 1.13– 
1.09  (dd,  J = 6.9 Hz,  3.2 Hz,  6H;  CH3CH),  0.88  (m,  24H; 2 x t-Bu, 
2 x CH3CH2),  0.05–0.04 ppm (series of  singlets due to  rotamers, 
12H; Si(CH3)2);  13C  NMR (100 MHz,  CDCl3,  22 oC, TMS):  d = 176.5 
(2 x C@O), 65.0   (2 x CH2O),   48.3   (2 x CHN),  43.4   (2 x CHCH3), 
36.7  (CHCH2CH), 27.5  (2 x CH3CH2), 25.9  (6 x CCH3), 18.3  (2 x C), 
17.5  (2 x CH3CH),  12.0  (2 x CH3CH2),  -5.3 ppm (2 x Si(CH3)2);  IR 
(neat):  m = 3294,  2957,  2932,  2862,  1642 cm-1    (C@O);  HRMS 
(ESI):  m/z calcd for  C27H58N2O4Si2-H+:  529.3857 [M-H+];  found: 
529.3880. 
	  
4.3.  Preparation of amide 8 
	  
Thionyl chloride (0.66 ml, 9.12  mmol) was  added to a ﬂask  con- 
taining (S)-(+)-2-phenylbutyric  acid  (1.1 ml,  6.1 mmol). The  solu- 
tion was  heated at reﬂux for  3 h and then concentrated in  vacuo. 
The  residue was  taken up  in  CH2Cl2  and concentrated once more 
to  remove any  remaining thionyl chloride. The  product was  then 
dissolved in  CH2Cl2  and added dropwise to  a solution of 6 (1.6 g, 
2.76  mmol) and triethylamine  (1.45 ml,  6.1 mmol) at 0 oC.  This 
solution was  left to stir  for 14 h, and then warmed to room temper- 
ature. The solution was  then concentrated in vacuo. Puriﬁcation by 
column chromatography (petrol/ethyl  acetate  80:20) yielded 8 
(1.08 g,  60%)  as  a  colourless  oil.  Rf = 0.64   (petrol/ethyl acetate 
80:20); ½a]20  ¼ -13:6 (c 0.003, CH3CN); 1H NMR (400 MHz,  CDCl3, 
ArC), 127.1 (2 x para ArC), 64.4  (2 x CH2O),  55.3  (2 x CHAr), 48.6 
(2 x CHN),  33.4   (CHCH2CH),  26.5   (2 x CH2CH3),  25.8   (6 x CCH3), 
18.2   (2 x CCH3),  12.5   (2 x CH3CH2),  -5.5 ppm (2 x Si(CH3)2);  IR 
(neat):  m = 3312,  2956,  2929,  2857,  1647 cm-1    (C@O);  HRMS 
(ESI):  m/z calcd for  C37H62N2O4Si2-H+:  653.4170 [M-H+];  found: 
653.4175. 
	  
4.5.  Preparation of ligand 9 
	  
To a solution of 7  (190 mg,  0.36  mmol) and p-toluenesulfonyl 
ﬂuoride (138 mg, 0.79  mmol) in dry  acetonitrile (10 ml) was  added 
DBU (118 lL, 0.79  mmol). The  mixture was  stirred at reﬂux over- 
night, cooled and concentrated in  vacuo. Puriﬁcation by  column 
chromatography (petrol/ethyl acetate 30:70) yielded 9  (52.6 mg, 
55%)  as  a  colourless  oil.  Rf = 0.06   (petrol/ethyl  acetate  80:20); 
½a]20  ¼ þ17:6  (c  0.003, CH3CN);  1H NMR (400 MHz,  CDCl3,  22 oC, 
TMS):  d = 4.38–4.30  (m,   2H;   one   of  CH2O),  4.25–4.14  (m,   2H; 
2 x CHN),  3.85   (t,  3J(H,H) = 8.1 Hz,  2H;  one   of  CH2O),  2.42–2.33 
(m,  2H;  2 x CHCH3),  1.76–1.71 (m,  2H;  CHCH2CH),  1.68–1.58 (m, 
2H;  one  of  CH2CH3),  1.52–1.41 (m,  2H;  one  of  CH2CH3),  1.14  (d, 
1J(H,H) = 6.9 Hz,   6H;   2 x CHCH3),   0.90 ppm  (t,   3J(H,H) = 7.3 Hz, 
6H;    2 x CH3CH2);    13C    NMR   (100 MHz,    CDCl3,    22 oC,    TMS): 
d = 171.2   (2 x C@N),   73.1    (2 x CH2O),    64.8    (2 x CHN),   47.3 
(CHCH2CH),      35.1      (2 x CHCH3),      27.2      (2 x CH2CH3),      17.4 
(2 x CHCH3),  11.7  ppm (CH3CH2);  IR (neat): m = 2971, 1669 cm-1 
+
 
22   C, TMS): d = 7.30–7.25 (m, 10H;  Ar-H), 6.05  (d, 1J(H,H) = 8.3 Hz,
 
(C   N);   HRMS   (ESI):   m/z  calcd  for   C   H
 
N O +H
 
:  267.2072
 
o 
2H;   2 x NH),  3.74–3.64  (m,   2H;   2 x CHN),  3.53–3.44  (m,   4H; 
2 x CH2OSi),  3.21   (t,   3J(H,H) = 7.4 Hz,  2H;   2 x CHAr),  2.21–2.09 
(m,  2H;  one  of CH2CH3),  1.84–1.73 (m,  2H;  one  of CH2CH3),  1.64 
(t,  3J(H,H) = 6.4 Hz,  2H;  CHCH2CH),  0.87   (t,  3J(H,H) = 7.4 Hz,  6H; 
@ 
[M+H+]; found: 262.2078. 
	  
4.6.  Preparation of ligand 10 
15   26   2   2 
2 x CH3CH2),  0.78–0.77 (series of  singlets due to  rotamers, 18H; 
2 x t-Bu), -0.01 to  -0.12 ppm (series of singlets due to  rotamers, 
12H; Si(CH3)2);  13C  NMR (100 MHz,  CDCl3,  22 oC, TMS):  d = 173.6 
(2 x C@O), 140.2 (2 x ArCCH), 128.8 (4 x meta/ortho ArC), 128.1 
(4 x meta/ortho ArC), 127.2 (2 x para ArC), 64.7  (2 x CH2O),  55.3 
(2 x CHAr),  48.5   (2 x CHN),  33.4   (CHCH2CH),  26.2   (2 x CH2CH3), 
To a solution of 8 (1.00  g, 2.2 mmol) and p-toluenesulfonyl ﬂuo- 
ride   (843 mg,  4.84  mmol) in  dry  acetonitrile (30 ml)  was   added 
DBU (724 lL, 4.84  mmol). The  mixture was  stirred at reﬂux over- 
night, cooled and concentrated in  vacuo. Puriﬁcation by  column 
chromatography    (petrol/ethyl    acetate    30:70)    yielded    10 
(316.8 mg,  37%) as  a colourless oil.  Rf = 0.56  (Petrol:ethyl acetate 
	  	   7	  
 
	  
30:70); ½a]20  ¼ -18:7 (c 0.003, CH3CN); 1H NMR (400 MHz,  CDCl3, 
22 oC,  TMS):  d = 7.29   (m,  10H;   Ar-H),  4.30–4.38 (m,  2H;  one   of 
CH2O),  4.19–4.27 (m,   2H;   2 x CHN),  3.82–3.88 (m,   2H;   one   of 
CH2O),  3.40–3.46 (m,  2H;   2 x CHAr),  2.01–2.10 (m,  2H;   one   of 
CH3CH2), 1.75–1.87 (m, 2H;  one  of CH3CH2), 1.70–1.74 (m, 2H; 
CHCH2CH),   0.89  ppm  (t,   3J(H,H) = 7.3 Hz,  6H;   2 x CH3CH2);   13C 
NMR  (100 MHz,  CDCl3,  22 oC,  TMS):  d = 168.8 (2 x C@N), 140.2 
(2 x ArCCH),  128.6  (4 x meta/ortho ArC),  128.0  (4 x meta/ortho 
ArC), 127.1 (2 x para ArC), 73.3  (2 x CH2O),  64.8  (2 x CHN), 47.3 
(2 x CHAr),    43.4     (CHCH2CH),    27.2     (2 x CH2CH3),    12.3  ppm 
(2 x CH3);  IR (neat) IR (neat): m = 2964, 2932, 1656 cm-1   (C@N); 
HRMS  (ESI):  m/z  calcd  for   C25H30N2O2-H+:  389.2229  [M-H+]; 
found: 389.2240. 
	  
4.7.  Preparation of ligand 11 
	  
To a solution of 13  (800 mg,  1.22  mmol) and p-toluenesulfonyl 
ﬂuoride (469 mg, 2.68  mmol) in dry  acetonitrile (30 ml) was  added 
DBU (400 lL, 2.68  mmol). The  mixture was  stirred at reﬂux over- 
night, cooled and concentrated  in  vacuo. Puriﬁcation by  column 
chromatography (petrol/ethyl acetate 20:80) yielded 11  (315 mg, 
66%)   as   a   yellow  oil.   Rf = 0.50    (petrol/ethyl  acetate  20:80); 
½a]20  ¼ þ59:8  (c  0.003, CH CN);  1H NMR (400 MHz,  CDCl , 22 oC, 
was  stirred for  a  further 15 min. The  catalyst was  transferred to 
the substrate–nucleophile mixture via  a  gas-tight syringe, along 
with a toluene rinse (1 mL). The reaction mixture was  then stirred 
at 80 oC for 60 h. At this point, a saturated NH4Cl solution (10 mL) 
was  added, the organic layer was  separated and the aqueous layer 
was  extracted with diethyl ether (3 x 10 mL).  The  combined or- 
ganic layers were washed with brine (10 mL),  dried over   anhy- 
drous Na2SO4,  ﬁltered and concentrated  in  vacuo to   yield the 
crude product. A 1H NMR  spectrum was   recorded to  determine 
the conversion [unreacted (±)-(E)-1,3-diphenyl-3-acetoxyprop-1- 
ene   signal at 2.14   (3H)  compared to  the product signal at 4.27 
(1H)].  The crude product was  then puriﬁed by column chromatog- 
raphy (pet. ether/ethyl acetate, 25:1). The enantiomeric excess (ee) 
of  the product was  then measured using chiral HPLC (CHIRACEL 
OD, 254  nm,  hexane (0.1% diethylamine):iso-propyl alcohol, 98:2, 
0.5 mL/min), t(R)  25.2,  t(S)  26.9. 
	  
4.10. General procedure for  the Diels–Alder reaction 
	  
To   a   ﬂame-dried   N2    ﬁlled  Schlenk  were  added  Cu(OTf)2 
(0.033 mmol, 10 mol  %), ligand (0.033 mmol, 10 mol  %), 4 Å pow- 
dered molecular sieves (20 mg)  and CH2Cl2   (2 mL).  This  mixture 
was  stirred under N2 for 90 min at room temperature. To this stir- 
D 3 3 
TMS):  d = 7.29  (m,  10H;  Ar-H),  4.40–4.35 (m,  2H;  one  of  CH2O), ring  catalyst was  added trans-(crotonoyl)-2-oxazolidinone (51 mg, 
4.28–4.17 (m,   2H;   2 x CHN),  3.88–3.81 (m,   2H;   one   of  CH2O), 
3.47–3.40 (m,  2H;  2 x CHAr), 2.12–2.00 (m,  2H;  one  of CH3CH2), 
1.88–1.79 (m,  2H;  one  of CH3CH2),  1.79–1.67 (m,  2H;  CHCH2CH), 
0.33  mmol)   and   freshly   distilled   cyclopentadiene   (0.10  ml, 
1.21  mmol).  The   reaction  proceeded  at  room  temperature  for 
16 h.  A mixture of endo  and exo products was  isolated as  an  oil. 
1 
0.88  ppm   (t,    3J(H,H) = 7.5 Hz,    6H;     2 x CH3CH2);    13C    NMR The  endo:exo product ratio was  measured by H NMR. The  crude 
(100 MHz,    CDCl3,    22 oC,    TMS):    d = 168.7   (2 x C@N),   140.1 
(2 x ArCCH),  128.5  (4 x meta/ortho ArC),  127.8  (4 x meta/ortho 
ArC), 127.0 (2 x para ArC), 73.3  (2 x CH2O),  64.6  (2 x CHN), 47.2 
(2 x CHAr),    43.4     (CHCH2CH),    27.0     (2 x CH2CH3),    12.2  ppm 
(2 x CH3);   IR  (neat):  m = 2964,  2932,  1657 cm-1    (C@N);  HRMS 
(ESI):  m/z calcd  for  C25H30N2O2-H+:  389.2229 [M-H+];  found: 
389.2238. 
	  
4.8.  General procedure for  asymmetric cyclopropanation 
catalysed by  ligand–Cu(I) complexes 
	  
A solution of  ligand (0.013 mmol) and [Cu(OTf)]2·C6H6   (3 mg, 
mixture was   then puriﬁed by  column chromatography (petrol/ 
ethyl acetate, 3:2) affording a  mixture of  endo  and exo  products 
as  a  colourless oil,  from which the enantiomeric excess (ee)   of 
the endo diastereomer was  measured on the puriﬁed product using 
chiral HPLC (CHIRACEL OD,  254  nm,   hexane/iso-propyl  alcohol, 
98:2, 1.0 ml/min), t(S) 22.5,  t(R)  28.5. 
	  
4.11. Computational studies 
	  
The  geometries of  the reaction intermediates and transition 
states were optimized using density functional theory (DFT) calcula- 
tions with the 6-31G(d) basis set, employing Becke’s three parame- 
22,23 
0.006 mmol) in CH2Cl2  (1 mL) was  stirred under a nitrogen atmo- terized Lee–Yang–Parr exchange functional (B3LYP), and using a 
sphere  at  room temperature  for   90 min  and  then  transferred 
through a cotton plug to  a ﬂame-dried N2-ﬁlled Schlenk. Styrene 
(690 lL, 5 mmol) was  then added. A solution of ethyldiazoacetate 
(137 lL,  1.2 mmol) in  dry  CH2Cl2   was  added over  approximately 
6 h via a syringe pump. After  the addition was  complete, the reac- 
tion was  stirred for an additional 12 h. The reaction was  then con- 
centrated in vacuo to afford the crude product. The conversion and 
trans/cis ratio were determined by 1H NMR. Flash  chromatography 
of the residue (petrol/EtOAc; 25:1) provided a mixture of trans/cis 
isomers. The  enantiomeric excess of each isomer was  determined 
by chiral GC (Cyclodex-B 30 m x 0.252 mm x 0.25  lm). 
	  
4.9.  General procedure for  the asymmetric allylic alkylation 
reactions 
	  
Tri(benzylideneacetone)dipalladium (10 mol  %) was  added to  a 
ﬂame  dried  N2  ﬁlled Schlenk. Next,   the BOX ligand (15 mol  %) 
was  weighed into a second ﬂame dried N2 ﬁlled Schlenk and dis- 
solved in toluene (1 mL). The ligand solution was  then transferred 
under N2, into the Schlenk containing the metal. The resulting mix- 
ture was  then stirred for  2 h  at 80 oC. Next,  NaH  (2.2 equiv), di- 
methyl malonate (2.0 equiv) and toluene (8 mL),  were weighed 
into a  third ﬂame dried N2  ﬁlled Schlenk. The  resulting solution 
was  stirred at 80 oC for  15 min,  before the addition of (±)-(E)-1,3- 
diphenyl-3-acetoxyprop-1-ene  (1 equiv)  in   toluene  (1 mL),  and 
GAUSSIAN 09 Programs suite.24Frequency analyses were carried out  at 
the same level  to test the nature of the intermediates and transition 
structures found, according to the correct number of negative eigen- 
values of the corresponding Hessian matrices, and the vibrational 
frequencies associated to  the negative eigenvalues. In some cases, 
single point energy calculations were carried out  using different 
functionals and basis sets, to  check the consistency of the results. 
Enantioselectivities were estimated based on the calculated relative 
Gibbs  free  energies of the TS, unless otherwise stated. 
	  
Acknowledgments 
	  
This  publication has  emanated from research conducted with 
the ﬁnancial support of  Science Foundation  Ireland (RFP/06/ 
CHO039). 
	  
References 
 
1. Evans, D. A.; Woerpel, K. A.; Hinman, M. M.;  Faul, M. M. J. Am. Chem. 
Soc. 1991,113,  726–728. 
2. Corey, E. J.; Imai, N.;  Zhang, H. Y. J. Am. Chem. Soc. 1991, 113,  728–
729. 
3. Desimoni, G.;  Faita, G.;  Jorgensen, K. A. Chem. Rev. 2006, 106,  3561–
3651. 
4. Carreiro, E.  P.;  Burke, A.  J.;  Ramalho, J.  P.  P.;   Rodrigues, A.  I.  
Tetrahedron: Asymmetry 2009, 20,  1272–1278. 
  
	  	  8	  
 
5. Garcia, J. I.;  Jimenez-Oses, G.;  Martinez-Merino, V.;  Mayoral, J. A.;  
Pires,  E.; Villalba, I. Chem.-A Eur.  J. 2007, 13,  4064–4073. 
6. Matsumoto, K.;  Jitsukawa, K.;  Masuda, H.  Tetrahedron Lett.  2005,  46, 
5687–5690. 
7. Evans, D. A.; Tregay, S. W.; Burgey, C. S.; Paras, N. A.; Vojkovsky, T. J. 
Am. Chem. Soc. 2000, 122,  7936–7943. 
8. Fabra, M. J.; Fraile, J. M.; Herrerias, C. I.; Lahoz, F. J.; Mayoral, J. A.; 
Perez, I. Chem. Commun. 2008, 5402–5404. 
9. Frain, D.;  Kirby, F.; McArdle, P.;  O’Leary, P. Synlett 2009, 1261–1264. 
10. Frain, D.;  Kirby, F.;  McArdle, P.;  O’Leary, P. Tetrahedron Lett.  2010,  
51,  4103–4106. 
11. Kirby, F.;  Frain, D.;  McArdle, P.;  O’Leary, P.  Catal. Commun. 2010,  11,  
1012–1016. 
12. Thorhauge, J.; Roberson, M.;  Hazell, R. G.; Jorgensen, K. A. Chem.-A Eur. 
J. 2002, 8, 1888–1898. 
13. Bartók, M. Chem. Rev. 2010, 110,  1663–1705. 
14. O’Leary, P.; Krosveld, N. P.; De Jong,  K. P.; Van  Koten, G.; Klein 
Gebbink, R. J. M. Tetrahedron Lett.  2004, 45,  3177–3180. 
15. Evans, D. A.; Johnson, J. S.; Burgey, C. S.; Campos, K. R. Tetrahedron 
Lett.  1999, 2879. 
16. McDonagh, C.; O’Leary, P. Tetrahedron Lett.  2009, 50,  979–982. 
17. Fraile, J. M.;  Garcia, J. I.; Martinez-Merino, V.; Mayoral, J. A.; Salvatella, 
L. J. Am.Chem. Soc. 2001, 123,  7616–7625. 
18. Fraile,  J.  M.;   Garcia,  J.  I.;   Gil,   M.   J.;  Martinez-Merino,  V.;   
Mayoral,  J.  A.; Salvatella, L. Chem.-A Eur.  J. 2004, 10,  758–765. 
19. Fraile, José  M.;  García, José  I.; Gissibl, A.; Mayoral, José  A.; Pires, E.; 
Reiser, O.; Roldán, M.;  Villalba, I. Chem. - pA Eur.  J. 2007, 13,  8830–
8839. 
20. Garcia, J. I.; Jimenez-Oses, G.;  Mayoral, J. A. Chem.-A Eur.  J. 2011, 17,  
529–539. 
21. Armarego, W.  L.;  Perrin, D.  D.  Puriﬁcation of  Laboratory Chemicals, 
4th ed., 1996, Elseiver 
22. Becke, A. D. J. Chem. Phys.  1993, 98,  5648–5652. 
23. Lee,  C. T.; Yang, W.  T.; Parr, R. G. Phys.  Rev. B 1988, 37,  785–789. 
24. Frisch,  M.   J.;  Trucks,  G.  W.;  Schlegel, H.  B.;  Scuseria,  G.  E.;  Robb,  
M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; 
Petersson, G. A.; Nakatsuji, H.;  Caricato, M.;  Li, X.;  Hratchian, H.  P.;  
Izmaylov, A. F.;  Bloino,  J.; Zheng, G.;   Sonnenberg, J.  L.;  Hada, M.;   
Ehara, M.;   Toyota,  K.;  Fukuda,  R.; Hasegawa, J.; Ishida, M.;  Nakajima, 
T.; Honda, Y.; Kitao, O.;  Nakai, H.;  Vreven, T.;  Montgomery, J.  A.;  
Peralta, J.  E.;  Ogliaro,  F.;  Bearpark, M.;   Heyd,  J.  J.; Brothers, E.; 
Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; 
Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; 
Cossi, M.; Rega, N.; Millam, J. M.;  Klene, M.;  Knox, J. E.; Cross, J. B.; 
Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; 
Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.;  Ochterski, J. W.; 
Martin, R. L.; Morokuma, K.;  Zakrzewski, V. G.; Voth, G. A.; Salvador, 
P.;  Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.;  Farkas; Foresman, J. 
B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision A.2 and 
B.01; Gaussian, Inc.: Wallingford CT, 2009. 
	  
